Cizzle Biotechnology (LON:CIZ) Posts Earnings Results

Cizzle Biotechnology (LON:CIZ) issued its quarterly earnings data on Wednesday. The company reported GBX (0.08) earnings per share (EPS) for the quarter, Digital Look Earnings reports.

Cizzle Biotechnology Price Performance

Cizzle Biotechnology stock opened at GBX 1.52 on Friday. The stock has a market capitalization of £6.48 million, a P/E ratio of -8.97 and a beta of 0.02. Cizzle Biotechnology has a 12-month low of GBX 1.20 and a 12-month high of GBX 3.90. The firm’s 50-day moving average is GBX 1.65 and its two-hundred day moving average is GBX 2.23.

Cizzle Biotechnology Company Profile

Cizzle Biotechnology Holdings Plc, together with its subsidiaries, engages in the development of an immunoassay test for the CIZ1B biomarker for the early detection of lung cancer in the United Kingdom. The company was formerly known as Cizzle Biotechnology Limited and changed its name to Cizzle Biotechnology Holdings Plc in May 2021. Cizzle Biotechnology Holdings Plc is headquartered in London, the United Kingdom.